Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Effect Of Recombinant Human Soluble Thrombomodulin On Clinical Outcomes Of patients With Coagulopathy After Hematopoietic Stem Cell Transplantation

SungGi Chi, Takayuki Ikezoe, MD. PhD, Asako Takeuchi, Kazuki Anabuki, Tsukie Kim, Mizu Sakai, Ayuko Taniguchi, Kazuto Togitani, Akihito Yokoyama

Blood (2013) 122 (21): 4803.

https://doi.org/10.1182/blood.V122.21.4803.4803

Published: 2013

Journal Articles

Recombinant Human Soluble Thrombomodulin Safely and Effectively Rescues Acute Promyelocytic Leukemia Patients From Disseminated Intravascular Coagulation.

Takayuki Ikezoe, Asako Takeuchi, Tsukie Kim, Kazuki Akabuki, Mizu Sakai, Ayuko Taniguchi, Tazuto Togitani, Akihito Yokoyama

Blood (2012) 120 (21): 2226.

https://doi.org/10.1182/blood.V120.21.2226.2226

Published: 2012

Journal Articles

STAT5A Regulates DNMT3 and Inactivates PTEN Tumor Suppressor Gene in CD34 + /CD38 − AML Cells

Asako Takeuchi, Chie Nishioka, Takayuki Ikezoe, Jing Yang, Akihito Yokoyama

Blood (2012) 120 (21): 4087.

https://doi.org/10.1182/blood.V120.21.4087.4087

Published: 2012

Journal Articles

CD82 Regulates STAT5/IL-10 and Supports Survival of Acute Myelogenous Leukemia Cells.

Chie Nishioka, Takayuki Ikezoe, Asako Takeuchi, Jing Yang, Akihito Yokoyama

Blood (2012) 120 (21): 2981.

https://doi.org/10.1182/blood.V120.21.2981.2981

Published: 2012

Journal Articles

Development of a Novel Treatment Strategy Targeting JAK2 in Acute Myelogenous Leukemia.

Shinsuke Kojima, Takayuki Ikezoe, MD, PhD, Jing Yang, Chie Nshioka, Asako Takeuchi, Mayuka Isaka, Mutsuo Furihata, Akihito Yokoyama

Blood (2009) 114 (22): 2619.

https://doi.org/10.1182/blood.V114.22.2619.2619

Published: 2009

Journal Articles

Inhibition of STAT5 by IL-1β or the Inhibitor of Janus Kinases Stimulates Dormant Human Leukemia Stem Cells and Sensitizes Them to Anti-Leukemia Agents.

Takayuki Ikezoe, Yang Jing, Chie Nishioka, Shinsuke Kojima, Asako Takeuchi, Akihito Yokoyama

Blood (2009) 114 (22): 1597.

https://doi.org/10.1182/blood.V114.22.1597.1597

Published: 2009

NARROW

Effect Of Recombinant Human Soluble Thrombomodulin On Clinical Outcomes Of patients With Coagulopathy After Hematopoietic Stem Cell Transplantation

Recombinant Human Soluble Thrombomodulin Safely and Effectively Rescues Acute Promyelocytic Leukemia Patients From Disseminated Intravascular Coagulation.

STAT5A Regulates DNMT3 and Inactivates PTEN Tumor Suppressor Gene in CD34 + /CD38 − AML Cells

CD82 Regulates STAT5/IL-10 and Supports Survival of Acute Myelogenous Leukemia Cells.

Development of a Novel Treatment Strategy Targeting JAK2 in Acute Myelogenous Leukemia.

Inhibition of STAT5 by IL-1β or the Inhibitor of Janus Kinases Stimulates Dormant Human Leukemia Stem Cells and Sensitizes Them to Anti-Leukemia Agents.

Email alerts

ASH Publications

American Society of Hematology

Effect Of Recombinant Human Soluble Thrombomodulin On Clinical Outcomes Of patients With Coagulopathy After Hematopoietic Stem Cell Transplantation

Recombinant Human Soluble Thrombomodulin Safely and Effectively Rescues Acute Promyelocytic Leukemia Patients From Disseminated Intravascular Coagulation.

STAT5A Regulates DNMT3 and Inactivates PTEN Tumor Suppressor Gene in CD34 + /CD38 − AML Cells

CD82 Regulates STAT5/IL-10 and Supports Survival of Acute Myelogenous Leukemia Cells.

Development of a Novel Treatment Strategy Targeting JAK2 in Acute Myelogenous Leukemia.

Inhibition of STAT5 by IL-1β or the Inhibitor of Janus Kinases Stimulates Dormant Human Leukemia Stem Cells and Sensitizes Them to Anti-Leukemia Agents.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only